A diagnostic model for cirrhosis in patients with non-alcoholic fatty liver disease: an artificial neural network approach

Authors

  • Hedieh Zabolinezhad Department of Medical Informatics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Omid Pournik Department of Community Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Saeid Eslami Pharmaceutical Research Center, School of Pharmacy, Mashhad, Iran, Department of Medical Informatics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Sara Dorri Department of Medical Informatics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:

  Background :Timely diagnosis of liver cirrhosis is vital for preventing further liver damage and giving the patient the chance of transplantation. Although biopsy of the liver is the gold standard for cirrhosis assessment, it has some risks and limitations and this has led to the development of new noninvasive methods to determine the stage and prognosis of the patients. We aimed to design an artificial neural network (ANN) model to diagnose cirrhosis patients with non-alcoholic fatty liver disease (NAFLD) using routine laboratory data.   Methods : Data were collected from 392 patients with NAFLD by the Middle East Research Center in Tehran. Demographic variables, history of diabetes, INR, complete blood count, albumin, ALT, AST and other routine laboratory tests, examinations and medical history were gathered. Relevant variables were selected by means of feature extraction algorithm (Knime software) and were accredited by the experts. A neural network was developed using the MATLAB software.   Results : The best obtained model was developed with two layers, eight neurons and TANSIG and PURLIN functions for layer one and output layer, respectively. The sensitivity and specificity of the model were 86.6% and 92.7%, respectively.   Conclusion : The results of this study revealed that the neural network modeling may be able to provide a simple, noninvasive and accurate method for diagnosing cirrhosis only based on routine laboratory data.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

a diagnostic model for cirrhosis in patients with non-alcoholic fatty liver disease: an artificial neural network approach

background :timely diagnosis of liver cirrhosis is vital for preventing further liver damage and giving the patient the chance of transplantation. although biopsy of the liver is the gold standard for cirrhosis assessment, it has some risks and limitations and this has led to the development of new noninvasive methods to determine the stage and prognosis of the patients. we aimed to design an a...

full text

Prevalence of gallstone disease in the patients with non-alcoholic fatty liver disease (NAFLD) in Sanandaj: A case control study

Background and Aim: Nonalcoholic fatty liver disease (NAFLD) and gallstone disease (GD) are both highly prevalent in the general population and have many risk factors in common. The aim of this study was to evaluate the prevalence of GD in the patients with NAFLD. Materials and Methods: In this case-control study, our case group included 145 patients with NAFLD and control group consisted of 21...

full text

Serum leptin levels in psoriatic patients with non-alcoholic fatty liver disease

Background: The prevalence of non-alcoholic fatty liver disease is higher in patients with psoriasis than in the normal population. Serum leptin levels are higher in patients with psoriasis and in patients with non-alcoholic fatty liver. The purpose of this study was to determine the serum levels of leptin in psoriatic patients with and without non-alcoholic fatty liver.<span...

full text

Cardiovascular disease in patients with non-alcoholic fatty liver disease

As it affects almost every third individual in the general population in the Western world, non-alcoholic fatty liver disease (NAFLD) represents the most common cause of chronic liver disease and the most common cause of liver transplantation. Recently, NAFLD has gained much attention in the metabolic field. A continuously increasing amount of evidence suggests that NAFLD is strongly associated...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 28  issue 1

pages  765- 770

publication date 2014-01

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023